CSL Ltd and Washington H. Soul Pattinson & Company Ltd Share Prices Worth Watching

2 min read | July 24, 2024 12:00 AM AEST | By Team Kalkine Media

CSL Ltd (ASX:CSL), a leading global biotechnology company, has seen its share price increase by 8.3% since the start of 2024. CSL is known for its innovative medicines that address serious medical conditions and contribute to public health. The company operates through three main divisions: 

  1. CSL Behring: Specializes in blood plasma products.
  2. CSL Seqirus: Focuses on flu-related products and pandemic services.
  3. CSL Vifor: Provides treatments for iron deficiency and kidney care.

CSL’s plasma collection unit is vital for producing life-saving treatments worldwide. The ASX healthcare stock's growth is driven by its emphasis on plasma and blood collections, alongside strategic acquisitions. CSL's performance indicators show a return on invested capital (ROIC) of 10.30% for FY23 and a revenue compound annual growth rate (CAGR) of 8.7% in recent years. These metrics reflect strong financial health and sustainability for this established business. 

Washington H. Soul Pattinson (ASX:SOL) 

Washington H. Soul Pattinson Ltd, founded in 1903, is a diversified investment company with a portfolio spanning various industries. Major holdings include stakes in TPG Telecom (ASX:TPG), New Hope Group (ASX:NHC), and Brickworks (ASX:BKW). As a family-run investment company, WHSP aims to deliver superior returns through capital growth and increasing dividends. 

Currently, WHSP shares are approximately 3% below their 52-week high. The company’s long-standing reputation and diversified portfolio make it a notable candidate for investors looking for stability and growth. 

For CSL Ltd, the current dividend yield stands at around 1.16%, slightly below its 5-year average of 1.24%. This suggests that CSL shares are trading below their historical average dividend yield, providing potential insights into current valuation levels. 

Both CSL and WHSP demonstrate strong performance and stability, making them worthy of consideration for inclusion on investment watchlists in 2024. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.